[ORGANIZATION]
TEZSPIRE
Featured in 4 tracked stories · first seen
Situations
Tezspire clinical trial results for EoE
2 clusters · 2 sources · last updated
Latest: Amgen and AstraZeneca report positive clinical trial results for specialized therapies
Clinical trial results from the phase III CROSSING study indicate that tezepelumab (Tezspire), developed by AstraZeneca and Amgen, shows significant improvement for adolescents and adults with symptomatic, uncontrolled e
Also covered in
-
AstraZeneca and Amgen report positive Phase III results for Tezspire in EoE treatment
[HEALTH] · 2 sources ·
-
Amgen and AstraZeneca report positive Phase 3 results for TEZSPIRE in EoE
[HEALTH] · 4 sources ·